-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, RFJyz7pADRJhIL+X8i6CYFW48cP8R453H11d/q8RkESY+iWv4mOgLfUhVprs5nFz LwJ+Xqkg6KCC7Ewtj7rKJw== 0000892251-10-000186.txt : 20100923 0000892251-10-000186.hdr.sgml : 20100923 20100923154331 ACCESSION NUMBER: 0000892251-10-000186 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20100917 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers FILED AS OF DATE: 20100923 DATE AS OF CHANGE: 20100923 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MERIDIAN BIOSCIENCE INC CENTRAL INDEX KEY: 0000794172 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 310888197 STATE OF INCORPORATION: OH FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-14902 FILM NUMBER: 101086770 BUSINESS ADDRESS: STREET 1: 3471 RIVER HILLS DR CITY: CINCINNATI STATE: OH ZIP: 45244 BUSINESS PHONE: 5132713700 MAIL ADDRESS: STREET 1: 3471 RIVER HILLS DRIVE CITY: CINCINNATI STATE: OH ZIP: 45244 FORMER COMPANY: FORMER CONFORMED NAME: MERIDIAN DIAGNOSTICS INC DATE OF NAME CHANGE: 19920703 8-K 1 form8k091710.htm FORM 8-K form8k091710.htm

 
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT
 
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported): September 17, 2010
 
MERIDIAN BIOSCIENCE, INC.
(Exact name of registrant as specified in its charter)
 

 
  Ohio  
0-14902
 
31-0888197
  (State or other jurisdiction of incorporation)  
(Commission File Number)
 
 
(IRS Employer Identification No. )
 
 
 
3471 River Hills Drive, Cincinnati, Ohio
 
45244
(Address of principal executive offices)
 
(Zip Code)
 

 
Registrant’s telephone number, including area code       (513) 271-3700
 
 
(Former name or former address, if changed since last report.)

 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
  o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
  o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
  o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
  o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
 
 

 

Item 5.02.  Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
 
(b)           On September 17, 2010 James A. Buzard, who is age 82 and resides in Lake Forest Illinois, informed Meridian Bioscience, Inc. Executive Chairman, William J. Motto, of his plans to retire from the Board at the end of his term in January 2011. He will not stand for re-election at the Company's 2011 Annual Meeting.  A director of the Company since 1990, Dr. Buzard serves as the Chairman of the Board's Nominating and Corporate Governance Committee. The Company is grateful for Dr. Buzard's many years of dedicated service.
 

SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
MERIDIAN BIOSCIENCE, INC.
 
 
       
Date:  September 23, 2010
By:
/s/ Melissa Lueke  
    Melissa Lueke  
   
Executive Vice President and Chief Financial Officer
 
    (Principal Accounting Officer)  
 
-----END PRIVACY-ENHANCED MESSAGE-----